Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Franzin L et al. |
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. |
2000 |
Curr. Microbiol. |
pmid:10594221
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Komatsu H et al. |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. |
1999 |
Br. J. Dermatol. |
pmid:10583068
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Tanigawara Y et al. |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10579481
|
de Luis DA et al. |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. |
1999 |
Clin Nutr |
pmid:10578022
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Mach T and Zahradnik-Bilska J |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. |
1999 |
Prz. Lek. |
pmid:10575912
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Adeyemi EO et al. |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10563537
|
MartÃn de Argila C and Boixeda D |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection]. |
1999 |
Med Clin (Barc) |
pmid:10562929
|
Valencia IC et al. |
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. |
1999 |
Int. J. Dermatol. |
pmid:10561050
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Hammett DC and Evans MF |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? |
1999 |
Can Fam Physician |
pmid:10540692
|
Gisbert JP et al. |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10540045
|
Saito H et al. |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice]. |
1999 |
Kekkaku |
pmid:10535281
|
Gonzalez Cueto D et al. |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. |
1999 |
Acta Gastroenterol. Latinoam. |
pmid:10533659
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Gibson JR et al. |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. |
1999 |
J. Clin. Microbiol. |
pmid:10523591
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Goldberg EI et al. |
Henoch-Schönlein purpura induced by clarithromycin. |
1999 |
Int. J. Dermatol. |
pmid:10517691
|
Foster SF et al. |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat. |
1999 |
J Small Anim Pract |
pmid:10516950
|
Rovira E et al. |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. |
1999 |
Respiration |
pmid:10516537
|
Gilljam M et al. |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. |
1999 |
Eur. Respir. J. |
pmid:10515412
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Galil K et al. |
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. |
1999 Sep-Oct |
Emerging Infect. Dis. |
pmid:10511524
|
Furuta T et al. |
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10511062
|
McMullin ST et al. |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. |
1999 |
Arch. Intern. Med. |
pmid:10510994
|
Uygun A et al. |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
1999 |
Clin Ther |
pmid:10509849
|
Gisbert JP et al. |
Re-treatment after Helicobacter pylori eradication failure. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503846
|